EPLAW PATENT BLOG

EPLAW – Young EPLAW UPC Moot 2017

Posted: May 22nd, 2017

The 2017 Young EPLAW Congress gave 20 volunteers the opportunity to participate in the project launched in 2013, called “How to plead a case” and kindly hosted again by HOYNG ROKH MONEGIER Brussels. During this mock case, two panels of two Board members sitting as mock judges each heard five sets of plaintiffs and defendants […]

READ MORE

UK – Unwired Planet v Huawei Technologies

Posted: December 3rd, 2015

Unwired Planet International Limited v (1) Huawei Technologies Co. Limited, (2) Huawei Technologies (UK) Co. Limited, (3) Samsung Electronics Co. Limited, (4) Samsung Electronics (UK) Limited & Others The English Patents Court has upheld the validity of EP (UK) 2 229 744, which relates to an efficient polling system for a wireless communications network and […]

READ MORE

NL – Sun v. Novartis / No skinny label injunction

Posted: December 3rd, 2015

Sun Pharmaceutical Industries (Europe) B.V. v. Novartis AG and Novartis Pharma GmbH, District Court of The Hague, The Netherlands, 25 November 2015, Case file number: C/09/469148 / HA ZA 14-770. In January of this year the Court of Appeal of The Hague in preliminary injunction proceedings held Sun liable for indirect infringement of Novartis’ Swiss […]

READ MORE

UK – Saab Seaeye v Atlas Electronic cs

Posted: December 3rd, 2015

Saab Seaeye Limited -v- Atlas Electronic GmbH and ECS Special Projects Limited and Adrian Dann and Blueprint Design Engineering Limited (t/a Blueprint Subsea) and James Barratt, High Court (Patents Court), Mr Justice Mann, 4 November 2015 The English Patents Court has partially upheld the validity of two patents, GB 2 482 576 (GB 576) and […]

READ MORE

UK – Warner-Lambert v Sandoz

Posted: December 3rd, 2015

Warner-Lambert Company LLC v Sandoz GmBH, Sandoz Limited and Lloyds Pharmacy Limited, England and Wales Patents Court (Arnold J), London, UK, 4 November 2015, Neutral Citation Number: [2015] EWHC 3153 (Pat) This judgment concerned an application for an interim injunction restraining Sandoz from any further dealing in its full label generic pregabalin product and Lloyds […]

READ MORE

EPO – First request by the Administrative Council that the EBA proposes the removal of a member of the BoA from office held inadmissible

Posted: December 3rd, 2015

Enlarged Board of Appeal, decision in case Art. 23 1/15 – Request for a proposal of removal from office Background Pursuant to Article 23 (1), 1st sentence, EPC, a member of the Boards of Appeal may not be removed from office during his term of 5 years, “except if there are serious grounds for such […]

READ MORE

FR – Ethypharm v. Alkermes Pharma Ireland

Posted: December 3rd, 2015

S.A. Ethypharm v. Alkermes Pharma Ireland Limited, Court of Appeal, Paris, France, 3 November 2015, No. 184/2015, with thanks to Raphaëlle Dequiré-Portier, GIDE LOYRETTE NOUEL, for sending in the case, together with a head note and translation in English In this decision, the Court of Appeal has reversed the First Instance decision of 21 December […]

READ MORE

BE – AstraZeneca v. Teva / AstraZeneca v. Sandoz

Posted: December 3rd, 2015

AstraZeneca AB v. Teva Pharma Belgium NV and AstraZeneca AB v. Sandoz NV, Court of Appeal Brussels, Belgium, 10 November 2015, and 9 November 2015, Case No. 2015/KR/20 and 2014/KR/232, with thanks to Carl De Meyer, Liesbeth Weynants and Carina Gommers, HOYNG ROKH MONEGIER, for sending in the cases and a head note in English […]

READ MORE

FR – Trilingual version Saisie-contrefaçon

Posted: December 3rd, 2015

Pierre Véron, Véron & Associés reports: Our book on the saisie-contrefaçon, often considered as the reference, is now available in trilingual version, German, English and French. Published in French in the Référence collection of the legal publisher Dalloz (3rd edition 2013), Saisie‑contrefaçon, the book, now translated in the other two main legal languages in Europe, presents […]

READ MORE